Cargando…
Octreotide and hepatocellular carcinoma
Autores principales: | Farinati, F, Sergio, A, Baldan, A, Zucchetta, P, Corleto, V D |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2359914/ https://www.ncbi.nlm.nih.gov/pubmed/17505506 http://dx.doi.org/10.1038/sj.bjc.6603799 |
Ejemplares similares
-
Megestrol treatment in patients with hepatocellular carcinoma
por: Farinati, F, et al.
Publicado: (2001) -
Octreotide to treat severe hypoglycaemia in Guillain-Barre syndrome
por: Palaniswamy, Sangeetha R., et al.
Publicado: (2022) -
Systemic hemodynamic and renal effects of midodrine and octreotide in cirrhotic patients with ascites
por: Kalambokis, Georgios N., et al.
Publicado: (2011) -
Octreotide in Palliative Treatment of Unresectable Cholangiocarcinoma: Is it Effective for Disease Stabilization?
por: Pistevou-Gompaki, Kiki, et al.
Publicado: (2008) -
Octreotide in Palliative Treatment of Hepatic Metastases: Is it Effective for Clinical Stabilization?
por: Pistevou-Gompaki, Kiki, et al.
Publicado: (2008)